Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | DEFA14A: Others
Black Diamond Therapeutics | DEF 14A: Definitive information statements
Black Diamond Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | DEFA14A: Others
No Data